申请人:Pfizer Inc
公开号:US07473787B2
公开(公告)日:2009-01-06
The present invention relates to a series of substituted bicyclic[3.1.0]amines of the Formula I:
wherein A, B, D, Q, V, W, X, Y, Z, R2, R3, R4, R5, R14, R15, R30. o, p, s,t and q are as defined in the specification, their pharmaceutically acceptable salts, pharmaceutical compositions thereof, and their use for the enhancement of cognition and the treatment of the positive and negative symptoms of schizophrenia and other psychoses in mammals, including humans.
本发明涉及一系列式I的取代双环[3.1.0]胺,其中A、B、D、Q、V、W、X、Y、Z、R2、R3、R4、R5、R14、R15、R30、o、p、s、t和q如规范所定义,它们的药学上可接受的盐、制药组合物以及它们在哺乳动物,包括人类中增强认知和治疗精神分裂症和其他精神病的阳性和阴性症状中的应用。